These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10231815)

  • 1. [Coincidence of schizophrenia and panic disorder].
    Rupprecht R; Ströhle A
    Nervenarzt; 1999 Mar; 70(3):265-8. PubMed ID: 10231815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined antidepressants and CBT for panic disorder with agoraphobia.
    Coupland NJ
    J Psychiatry Neurosci; 2008 Mar; 33(2):176. PubMed ID: 18330461
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined pharmacotherapy and cognitive behavior therapy in the treatment of panic disorder.
    Gelder MG
    J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):2S-5S. PubMed ID: 9872706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of agoraphobia with panic disorder.
    Perugi G; Frare F; Toni C
    CNS Drugs; 2007; 21(9):741-64. PubMed ID: 17696574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the cost and the effectiveness of a psychotherapy for panic disorder with agoraphobia (PDA) versus a treatment combining pharmacotherapy and psychotherapy].
    Marchand A; Germain V; Reinharz D; Mainguy N; Landry P
    Sante Ment Que; 2004; 29(2):201-20. PubMed ID: 15928793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panic disorder with or without concomitant depression 5 years after treatment: a prospective follow-up.
    Albus M; Scheibe G; Scherer J
    J Affect Disord; 1995 May; 34(2):109-15. PubMed ID: 7665802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of treatments for panic disorder with agoraphobia: imipramine, alprazolam, and in vivo exposure.
    Cox BJ; Endler NS; Lee PS; Swinson RP
    J Behav Ther Exp Psychiatry; 1992 Sep; 23(3):175-82. PubMed ID: 1487535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia?
    Oei TP; Llamas M; Evans L
    Behav Res Ther; 1997 Sep; 35(9):851-7. PubMed ID: 9299805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary evidence for cognitive mediation during cognitive-behavioral therapy of panic disorder.
    Hofmann SG; Meuret AE; Rosenfield D; Suvak MK; Barlow DH; Gorman JM; Shear MK; Woods SW
    J Consult Clin Psychol; 2007 Jun; 75(3):374-9. PubMed ID: 17563154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
    Mavissakalian MR; Perel JM
    Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipramine treatment of panic disorder with agoraphobia: the second time around.
    Mavissakalian MR; Perel JM; de Groot C
    J Psychiatr Res; 1993; 27(1):61-8. PubMed ID: 8515390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-life-onset panic disorder: clinical and demographic characteristics of a patient sample.
    Hassan R; Pollard CA
    J Geriatr Psychiatry Neurol; 1994; 7(2):84-8. PubMed ID: 8204193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of medical services and treatment for panic disorder with agoraphobia and for social phobia.
    Swinson RP; Cox BJ; Woszczyna CB
    CMAJ; 1992 Sep; 147(6):878-83. PubMed ID: 1525731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical picture and treatment of agoraphobia with panic disorder].
    Litvintsev SV; Reznik AM; Kvashnina NV; Arbuzov AL; Krylov KE
    Voen Med Zh; 2003 Jun; 324(6):53-9. PubMed ID: 12916423
    [No Abstract]   [Full Text] [Related]  

  • 16. The structure of phobias in panic disorder.
    Argyle N; Solyom C; Solyom L
    Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grief, psychosis, and panic intervention with a psychotic patient: integrating psychodynamic and cognitive-behavioral approaches.
    Yang LH; Apfel RJ; Hofmann SG
    Harv Rev Psychiatry; 2002; 10(2):100-8. PubMed ID: 11897750
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
    Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
    Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia.
    Mavissakalian MR; Perel JM
    Ann Clin Psychiatry; 2001 Jun; 13(2):63-7. PubMed ID: 11534926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of outcome in panic disorder: a 5-year prospective follow-up study.
    Scheibe G; Albus M
    J Affect Disord; 1996 Nov; 41(2):111-6. PubMed ID: 8961038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.